产品详情
靶点信息
B-Raf (V600E) | ||||
4 nM(EC50) |
In vitro | DMSO | 93 mg/mL (172.22 mM) | |
Water | Insoluble | ||
Ethanol | 93 mg/mL (172.22 mM) | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 18.52 mL | 92.59 mL | 185.18 mL |
0.5 mM | 3.7 mL | 18.52 mL | 37.04 mL |
1 mM | 1.85 mL | 9.26 mL | 18.52 mL |
5 mM | 0.37 mL | 1.85 mL | 3.7 mL |
*The above data is based on the productmolecular weight 540.01. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A13226 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 540.01 |
Formula | C22H27ClFN7O4S |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 1269440-17-6, 1269440-29-0 |
Synonyms | LGX818, LGX-818 |
SMILES | C[C@@H](CNC1=NC=CC(=N1)C2=CN(N=C2C3=CC(=CC(=C3F)NS(=O)(=O)C)Cl)C(C)C)NC(=O)OC |
产品资料
产品标签
Product Questions
Product Questions
Dabrafenib (GSK2118436A)
Dabrafenib (GSK2118436A)是一种有效且选择性的B-RAF蛋白激酶抑制剂,具有V600E突变,目前正在临床试验中。
NVP-BHG712
NVP-BHG712是EphB4激酶的选择性抑制剂,在体外对EphB4的选择性超过40多种其他激酶(包括FGFR3)。
Dabrafenib Mesylate
Dabrafenib Mesylate是一种新颖,有效和选择性的Raf激酶抑制剂,能够抑制野生型B-Raf,B-RafV600E和c-Raf的激酶活…
Balamapimod (MKI-833)
Balamapimod (MKI-833)是Ras/Raf/MEK抑制剂。